Correlation Between Oncolytics Biotech and Verizon Communications
Can any of the company-specific risk be diversified away by investing in both Oncolytics Biotech and Verizon Communications at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Oncolytics Biotech and Verizon Communications into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Oncolytics Biotech and Verizon Communications CDR, you can compare the effects of market volatilities on Oncolytics Biotech and Verizon Communications and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Oncolytics Biotech with a short position of Verizon Communications. Check out your portfolio center. Please also check ongoing floating volatility patterns of Oncolytics Biotech and Verizon Communications.
Diversification Opportunities for Oncolytics Biotech and Verizon Communications
0.27 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Oncolytics and Verizon is 0.27. Overlapping area represents the amount of risk that can be diversified away by holding Oncolytics Biotech and Verizon Communications CDR in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Verizon Communications and Oncolytics Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Oncolytics Biotech are associated (or correlated) with Verizon Communications. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Verizon Communications has no effect on the direction of Oncolytics Biotech i.e., Oncolytics Biotech and Verizon Communications go up and down completely randomly.
Pair Corralation between Oncolytics Biotech and Verizon Communications
Assuming the 90 days trading horizon Oncolytics Biotech is expected to generate 5.37 times more return on investment than Verizon Communications. However, Oncolytics Biotech is 5.37 times more volatile than Verizon Communications CDR. It trades about 0.08 of its potential returns per unit of risk. Verizon Communications CDR is currently generating about -0.24 per unit of risk. If you would invest 122.00 in Oncolytics Biotech on October 12, 2024 and sell it today you would earn a total of 8.00 from holding Oncolytics Biotech or generate 6.56% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Oncolytics Biotech vs. Verizon Communications CDR
Performance |
| Timeline |
| Oncolytics Biotech |
| Verizon Communications |
Oncolytics Biotech and Verizon Communications Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Oncolytics Biotech and Verizon Communications
The main advantage of trading using opposite Oncolytics Biotech and Verizon Communications positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Oncolytics Biotech position performs unexpectedly, Verizon Communications can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Verizon Communications will offset losses from the drop in Verizon Communications' long position.| Oncolytics Biotech vs. Theratechnologies | Oncolytics Biotech vs. Aptose Biosciences | Oncolytics Biotech vs. Resverlogix Corp |
| Verizon Communications vs. TGS Esports | Verizon Communications vs. Monument Mining Limited | Verizon Communications vs. Gamehost | Verizon Communications vs. Oncolytics Biotech |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Other Complementary Tools
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments |